This is a federal contract award to Abbott Laboratories Inc., a global healthcare company, by the Medical Supply Chain division of the U.S. Department of Defense. The contract, identified as SPE2DE24DA010|SPE2D625F5U8W, is a delivery order with a fixed price and economic price adjustment pricing type. The contract has a ceiling value of $28,350.00 and an ultimate completion date of May 7, 2025. This contract is not set aside and was awarded through full and open competition. Abbott...
This federal contract award, valued at $21,425.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company specializing in medical devices and equipment. The contract is a fixed-price delivery order with economic price adjustment, with a completion date of May 21, 2025. Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been a critical supplier of advanced cardiovascular medical technologies to federal agencies, particularly...
This is a federal contract award to Abbott Laboratories Inc., a global healthcare company, to supply medical devices and technologies to the U.S. government. The $3,527.00 fixed-price delivery order is awarded by the Medical Supply Chain, a Defense agency, for the delivery of various cardiovascular medical products such as stents, pacemakers, heart valves, and specialized surgical implants. The contract has an ultimate completion date of June 20, 2025. Abbott Laboratories holds multiple...
This federal contract award, valued at $48,634.70, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company and medical device manufacturer. The contract is a Delivery Order under a larger Indefinite Delivery Vehicle (IDV), with a period of performance ending on July 31, 2024. The award covers the delivery of a range of cardiovascular medical devices and related equipment, including implantable cardiac monitors, surgical implants, and...
This federal contract award, valued at $1,419.00, was issued to Abbott Laboratories Inc., a global healthcare company headquartered in North Chicago, Illinois. The contract is a delivery order for fixed-price medical supplies with economic price adjustment, awarded by the Medical Supply Chain division of a U.S. government defense agency. The contract has no set-aside designation, indicating full and open competition. Abbott Laboratories Inc., through its Abbott Vascular Inc. division, is a...
This federal contract award, valued at $14,850.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The award is a Delivery Order contract with a fixed price and economic price adjustment pricing type. The contract has an ultimate completion date of January 31, 2025 and does not include a set-aside designation, indicating full and open competition. Abbott Laboratories Inc. is a major pharmaceutical and medical device...
This is a federal contract award to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The contract, valued at $25,364.85, was awarded by the Defense Logistics Agency (DLA) and is a fixed-price delivery order contract with economic price adjustment. The contract has a completion date of February 5, 2025 and does not include a set-aside designation, indicating full and open competition....
This federal contract award was made by the U.S. Department of Defense's Medical Supply Chain to Abbott Laboratories Inc.'s Abbott Vascular Inc. division. The $11,750.00 fixed-price delivery order with economic price adjustment has a completion date of June 23, 2025. The contract does not have a set-aside designation, indicating full and open competition. Abbott Laboratories Inc. is a global healthcare company that specializes in medical devices, diagnostic equipment, and pharmaceuticals....
This federal contract award, valued at $27,735.77, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a large multinational pharmaceutical and medical device manufacturer, through its Abbott Vascular Inc. division. The contract is a Delivery Order with a Fixed Price and Economic Price Adjustment pricing type, with an ultimate completion date of November 27, 2024. The contract does not include a set-aside designation, indicating the award was made through full and...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company, for the delivery of medical devices and supplies. The contract, valued at $18,308.00, has an ultimate completion date of April 15, 2025. It is not set aside for any specific business category. The contract is for the provision of cardiovascular medical technologies, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping...